Health

Tennessee’s GOP-controlled Statehouse recently passed a bill that penalizes adults who assist minors in receiving gender-affirming care without parental consent. This legislation marks a significant development in the ongoing national debate over LGBTQ+ rights and healthcare. The bill, which is awaiting Governor Bill Lee’s signature, closely mirrors another anti-abortion trafficking proposal that was recently approved
0 Comments
A recent study conducted by Chinese researchers introduced a novel treatment approach for patients with relapsed or refractory hematologic cancers. This strategy combines sequential CD7 chimeric antigen receptor (CAR) T-cell therapy with haploidentical hematopoietic stem-cell transplantation (HSCT), without the use of graft-versus-host disease (GVHD) prophylaxis. The findings of this study, published in the New England
0 Comments
The recent news of the tragic death of Dr. Marsha Certain, an interventional cardiologist, in an apparent murder-suicide is deeply concerning. As a healthcare professional, Dr. Certain dedicated her life to saving others, making her untimely death heartbreaking for her colleagues and patients. This incident sheds light on the importance of mental health and support
0 Comments
When renowned medical news publications such as the New England Journal of Medicine start excluding certain publications from advanced access to embargoed journal articles, it begs the question – is this the medical field’s version of a ‘don’t ask, don’t tell’ policy? The sharp criticism from experts like Ivan Oransky, MD, highlights the potential implications
0 Comments
A groundbreaking treatment candidate for amyotrophic lateral sclerosis (ALS) has shown promising results in the phase IIb PARADIGM trial. Developed as a formulation of two FDA-approved drugs, ciprofloxacin and celecoxib, PrimeC demonstrated positive safety outcomes for ALS patients, with similar results to those treated with a placebo. Massachusetts General Hospital’s Merit Cudkowicz, MD, MSc, presented
0 Comments